Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.

Prospective study to validate clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer

Prospective study to validate clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer

The clinical efficacy of DNA cytology test (CY) in gastric cancer (GC) has been retrospectively proposed utilizing cancer-specific methylation of the Cysteine dioxygenase sort 1 (CDO1). We confirmed its clinical utility of DNA CY in a potential cohort. Four hundred GC samples had been prospectively collected for laundry cytology (UMIN000026191), and detection of the DNA […]

Prospective study to validate clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer Read More »

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.

OBJECTIVETo examine, utilizing a Dutch mannequin, whether or not and underneath what variables framed for different European nations screening for human papillomavirus (HPV) is most popular over cytology screening for cervical cancer, and to calculate the popular variety of examinations over a lady’s lifetime. METHODSCost effectiveness analysis based on a Dutch simulation mannequin. Base case analyses investigated the cost

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model. Read More »